DUBLIN., Vasorum Ltd. The developer and manufacturer of the novel Celt ACD® vascular closure device has received approval of its PMA application from the US Food and Drug Administration (FDA). Celt ...
CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
Irish devicemaker Vasorum got FDA approval for its Celt ADC vascular closure device that is aimed at arterial puncture closure. The device is indicated for both diagnostic and anticoagulated ...
Vasorum Ltd. announced that its vascular closure device has been approved by the FDA for use in interventional cardiology and interventional radiology procedures. The device (Celt ACD) is indicated ...
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual compression for artery closure in women undergoing transfemoral angiography. Researchers ...
DUBLIN--(BUSINESS WIRE)--The "Japan Market Report for Coronary Vascular Closure Devices 2018 - MedCore" report has been added to ResearchAndMarkets.com's offering. The gold standard in this market is ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Scientists at CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, will ...
Cardiac catheterization begins with arterial access and ends with access-site closure, both of which are fundamental to the safe performance of diagnostic and interventional procedures The preferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback